Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07606066 · ClinicalTrials.gov registry record
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
A clinical trial, sponsored by AstraZeneca.
- Recruiting
- Registry status
- 2,150
- Enrollment target
NCT07606066 is a clinical trial that is actively recruiting participants, run by AstraZeneca. The registered enrollment target is 2,150 participants.
The verdict
NCT07606066 is actively recruiting participants, sponsored by AstraZeneca.
- RECRUITING
- Registry status
- 2,150 participants
- Enrollment target
Study Summary
The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions.
Interventions
- OTHER Procedure: assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,150 participants |
| Start Date | 2026-05-06 |
| Est. Completion | 2027-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07606066
The ClinicalTrials.gov registry entry for NCT07606066 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Procedure: assessment is the first listed.
NCT07606066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07606066 about?
NCT07606066 is a clinical study titled "A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies". The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical r...
What is the current status of trial NCT07606066?
This trial is currently recruiting. The enrollment target is 2,150 participants. The study started on 2026-05-06. Estimated completion is 2027-03-31.
What interventions are being tested in trial NCT07606066?
The interventions under investigation include: Procedure: assessment (OTHER).
Who is sponsoring clinical trial NCT07606066?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.